- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
Pages tagged "United Nations"
-
ASA Members Move International Rescheduling Process Forward
Posted on Blogs by Americans for Safe Access · December 26, 2016 5:54 PM
Read moreAmericans for Safe Access (ASA) has just learned that the World Health Organization’s Expert Committee on Drug Dependence (ECDD) decided to move forward with a process that may reclassify medical cannabis under international law. The debate about medical cannabis at the ECDD has been stalled for years, but persistent pressure by ASA members, staff and international allies has resulted in historic movement towards rescheduling. The influential committee will hold a special session to discuss medical cannabis in eighteen months.
-
Help put a copy of ASA's groundbreaking report on medical cannabis science and policy in the hands of every UN delegate next week
Posted on Blogs by Americans for Safe Access · April 13, 2016 8:00 AMWhen the United Nations General Assembly Special Session (UNGASS) convenes in New York next Tuesday, delegates will be discussing global drug policy – including what to do about medical cannabis. This is a historic meeting, and the ramifications for national and international medical cannabis policy could be huge.
ASA would like to provide every delegate from the 180 nations represented with a groundbreaking report we prepared this year for the UN Commission on Narcotic Drugs. The 91-page report, which was peer-reviewed at our annual conference in March, answers important scientific questions about medical cannabis, and outlines a pathway towards international reform.
Pictured: ASA Executive Director Steph Sherer and an international delegation from France, the Czech Republic, the Netherlands, and Jamaica delivering the report to the UNCND in March.
Read more -
Unity16 participants have a unique chance in influence the United Nations
Posted on Blogs by Americans for Safe Access · March 17, 2016 4:45 PMYou have an important job to do, if you are attending ASA’s National Medical Cannabis Unity Conference, March 18-22, at the Lowes Madison Hotel in Washington, DC. We will be finalizing a document at the conference that will be submitted to the United Nations Commission on Narcotic Drugs (CND).
The CND meeting in Vienna coincides with the ASA Unity Conference this year. Unity Conference participants will have the opportunity to weigh in on this review document on Sunday March 20th in special stakeholder meetings. Allies within the CND will be calling on the CND, WHO, and UNGASS to use this Critical Review Preparation Document as a stepping-stone to move international cannabis policy forward.
Read more